Browse Category

Investor News News 6 November 2025 - 18 November 2025

Olema Pharmaceuticals (OLMA) Soars Over 200% After Roche Breast Cancer Trial Win — What It Means for Palazestrant and Investors on November 18, 2025

Olema Pharmaceuticals (OLMA) Soars Over 200% After Roche Breast Cancer Trial Win — What It Means for Palazestrant and Investors on November 18, 2025

Why OLMA Stock Is Exploding Today Olema Pharmaceuticals didn’t publish a press release or file anything with the SEC this morning. Yet, its stock rocketed nearly threefold in pre‑market trading on Tuesday, November 18, 2025. TipRanks+1 The real catalyst comes
Duolingo (DUOL) Plunges After Soft Q4 Bookings Outlook Despite Q3 Beat; Daily Users Top 50 Million — What to Know Today (Nov. 6, 2025)

Duolingo (DUOL) Plunges After Soft Q4 Bookings Outlook Despite Q3 Beat; Daily Users Top 50 Million — What to Know Today (Nov. 6, 2025)

Duolingo shares sank ~20% in after-hours trading Wednesday and extended losses into Thursday’s premarket, where they were seen down roughly 22%–26% as traders digested the softer Q4 bookings outlook despite strong Q3 results. Premarket indications on MarketWatch showed DUOL near
Go toTop